Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05229926 · ClinicalTrials.gov registry record
Implementation of CareCube Negative Pressure Isolation Units
A clinical trial of Infectious Disease, sponsored by Saint Luke's Health System.
- Completed
- Registry status
- 16
- Enrollment target
- 1
- Study location
NCT05229926: Completed study of Infectious Disease, sponsored by Saint Luke's Health System.
NCT05229926 is a study of Infectious Disease that has completed, run by Saint Luke's Health System. The registered enrollment target is 16 participants, below the 7,024-participant average among 18 other Infectious Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05229926, a study of Infectious Disease, has completed, sponsored by Saint Luke's Health System.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
Pilot study to provide a descriptive analysis of the real-world feasibility of using a CareCube for COVID-19 patients in a high-volume tertiary care hospital.
Primary Outcome
success of obtaining nasal swab as assessed by observer (successful/not successful)
Conditions Studied
Interventions
- DEVICE CareCube
Study Locations (1)
Missouri
- Saint Luke's Hospital of Kansas City - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2021-03-27 |
| Est. Completion | 2021-03-27 |
What the finished NCT05229926 record still lists
NCT05229926 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 7,024-participant average among 18 other Infectious Disease trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Infectious Disease appearing as the primary indexed condition, and to 1 intervention - of which CareCube is the first listed.
NCT05229926 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT05229926 about?
NCT05229926 is a clinical study titled "Implementation of CareCube Negative Pressure Isolation Units". Pilot study to provide a descriptive analysis of the real-world feasibility of using a CareCube for COVID-19 patients in a high-volume tertiary care hospital.
What is the current status of trial NCT05229926?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2021-03-27. Estimated completion is 2021-03-27.
What conditions does trial NCT05229926 study?
This clinical trial studies the following conditions: Infectious Disease.
What interventions are being tested in trial NCT05229926?
The interventions under investigation include: CareCube (DEVICE).
Who is sponsoring clinical trial NCT05229926?
This trial is sponsored by Saint Luke's Health System, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05229926 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infectious Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05229926's enrollment target sits among peer trials
16 18th of 18 higher than 1 of 18 other Infectious Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infectious Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Compliant Analysis of Patient Samples and Data
RECRUITING
-
Collection and Distribution of Biospecimens for Novel Research Uses
RECRUITING
-
Ocular Pathogen and Transcriptome Investigation Using Comprehensive Sequencing
RECRUITING · NA
-
Triage Survey for Infectious Disease Eligibility
RECRUITING
-
Antibiotics for Delirium in Older Adults With No Clear Urinary Tract Infection
RECRUITING · NA
-
Pharmacogenomics for Better Treatment of Fungal Infections in Cancer
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI